Literature DB >> 22401669

Clinical and genetic characterization of a 2-year-old boy with complete PLP1 deletion.

Hiroyuki Torisu1, Akiko Iwaki, Kenzo Takeshita, Akio Hiwatashi, Masafumi Sanefuji, Yasuyuki Fukumaki, Toshiro Hara.   

Abstract

We report herein a case of 2-year-old boy diagnosed with a mild form of Pelizaeus-Merzbacher disease due to deletion of the entire proteolipid protein 1 (PLP1) gene. The patient demonstrated spastic quadriplegia, mental retardation, and microcephaly. He exhibited brainstem auditory evoked potentials with prolonged interpeak latencies and magnetic resonance imaging characteristics suggestive of hypomyelination in most areas of the brain with the exception of the brainstem, cerebellar peduncles, corpus callosum, and the posterior limbs of the internal capsules. Proton magnetic resonance spectroscopy revealed a mildly reduced ratio of N-acetyl aspartate to creatine levels in the white matter, suggesting axonal involvement. Additionally, nerve conduction velocity of the lower extremities was mildly decreased. Genetic analysis showed a deletion of PLP1 in this patient. Further genome mapping followed by sequence analysis of the deletion breakpoints revealed that a genomic region, about 73 kb in length, including the entire PLP1 and RAB9B, was deleted. The size of the deletion was the smallest among those previously reported in this region. Except for the 1-base pair microhomology, there were no homologous sequences between the regions around the distal and proximal breakpoints, which suggests that the deletion occurred by nonhomologous end joining.
Copyright © 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401669     DOI: 10.1016/j.braindev.2012.02.006

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  7 in total

1.  Prioritizing genes for X-linked diseases using population exome data.

Authors:  Xiaoyan Ge; Pui-Yan Kwok; Joseph T C Shieh
Journal:  Hum Mol Genet       Date:  2014-09-12       Impact factor: 6.150

2.  Xq22 deletions and correlation with distinct neurological disease traits in females: Further evidence for a contiguous gene syndrome.

Authors:  Hadia Hijazi; Fernanda S Coelho; Claudia Gonzaga-Jauregui; Laura Bernardini; Soe S Mar; Melanie A Manning; Andrea Hanson-Kahn; SakkuBai Naidu; Siddharth Srivastava; Jennifer A Lee; Julie R Jones; Michael J Friez; Thomas Alberico; Barbara Torres; Ping Fang; Sau Wai Cheung; Xiaofei Song; Angelique Davis-Williams; Carly Jornlin; Patricia A Wight; Pankaj Patyal; Jennifer Taube; Andrea Poretti; Ken Inoue; Feng Zhang; Davut Pehlivan; Claudia M B Carvalho; Grace M Hobson; James R Lupski
Journal:  Hum Mutat       Date:  2019-11-14       Impact factor: 4.878

3.  Yeast Two-Hybrid Screening for Proteins that Interact with the Extracellular Domain of Amyloid Precursor Protein.

Authors:  You Yu; Yinan Li; Yan Zhang
Journal:  Neurosci Bull       Date:  2016-03-09       Impact factor: 5.203

4.  Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.

Authors:  Jeremy J Laukka; John Kamholz; Denise Bessert; Robert P Skoff
Journal:  Neurosci Lett       Date:  2016-05-17       Impact factor: 3.046

5.  An emerging phenotype of Xq22 microdeletions in females with severe intellectual disability, hypotonia and behavioral abnormalities.

Authors:  Toshiyuki Yamamoto; Anna Wilsdon; Shelagh Joss; Bertrand Isidor; Anna Erlandsson; Mohnish Suri; Noriko Sangu; Shino Shimada; Keiko Shimojima; Cédric Le Caignec; Lena Samuelsson; Margarita Stefanova
Journal:  J Hum Genet       Date:  2014-03-20       Impact factor: 3.172

6.  Insertion of an extra copy of Xq22.2 into 1p36 results in functional duplication of the PLP1 gene in a girl with classical Pelizaeus-Merzbacher disease.

Authors:  Julien Masliah-Planchon; Céline Dupont; George Vartzelis; Aurélien Trimouille; Eléonore Eymard-Pierre; Mathilde Gay-Bellile; Florence Renaldo; Imen Dorboz; Cécile Pagan; Samuel Quentin; Monique Elmaleh; Christina Kotsogianni; Elissavet Konstantelou; Séverine Drunat; Anne-Claude Tabet; Odile Boespflug-Tanguy
Journal:  BMC Med Genet       Date:  2015-09-02       Impact factor: 2.103

7.  A microdeletion at Xq22.2 implicates a glycine receptor GLRA4 involved in intellectual disability, behavioral problems and craniofacial anomalies.

Authors:  Jonathan D J Labonne; Tyler D Graves; Yiping Shen; Julie R Jones; Il-Keun Kong; Lawrence C Layman; Hyung-Goo Kim
Journal:  BMC Neurol       Date:  2016-08-09       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.